EOD vs EOT

The deterministic health profile is severely compromised with a Piotroski F-Score of 1/9, indicating critical weakness in traditional financial health metrics. However, this is contrasted by a strong valuation profile, with the current price of $6.31 trading at a significant discount to its intrinsic value of $9.87 and a very low P/E of 4.48. While long-term price performance is robust (5Y +85.8%), the current technical trend is heavily bearish (10/100). The asset functions as a high-yield income vehicle rather than a growth company, making traditional corporate health scores misleading but mandatory for this risk assessment.

EOT exhibits severe financial weakness as evidenced by a Piotroski F-Score of 1/9, indicating a critical lack of positive fundamental trends. The most alarming metric is a dividend payout ratio of 258.77%, which suggests the trust is returning capital or utilizing unsustainable leverage to maintain its 4.78% yield. With a technical trend score of 0/100 and a negative 5-year price change, the asset shows no signs of long-term strength despite a recent one-year recovery. The absence of traditional valuation metrics is typical for a closed-end trust, but the deterministic health scores signal high risk.